ROME Therapeutics

Verified

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Company News ROME Therapeutics Team Profile Biotech Startups Series B Route United States News

About ROME Therapeutics

ROME Therapeutics is tracked on 100Xfounder as a biotech company, founded in 2020, based in Boston, Massachusetts, USA, currently mapped to the Series B stage. ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Profile snapshot: Founders linked: ROME Therapeutics Team. Funding tracked: $50.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

ROME Therapeutics appears in the 100Xfounder startup directory import feed.

Why it Matters

ROME Therapeutics is worth tracking because its funding history is already mapped here, including a $50.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and ROME Therapeutics Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $50.00MLast Round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuationAll Rounds: 1

Series B | Andreessen Horowitz, $50M Series B in 2021, $70M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

ROME Therapeutics Team

Founder & CEO

Founder Profile LinkedIn

Tech Stack

AWSReactPythonPostgreSQL

Last updated: June 1, 2026

ROME Therapeutics research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

Company summary
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Founders covered
ROME Therapeutics Team
Market position
Biotech | Series B | Boston, Massachusetts, USA
Newsroom signal
No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.
Funding signal
$50.00M

Best next clicks

Company News Hub ROME Therapeutics Team United States News Biotech Startups Series B Funding News

Active topics

Startup News Founder Intelligence

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Biotech with comparable market signals.

NewLimit

NewLimit Team

View Company Industry Hub

Hoxton Farms

Hoxton Farms Team

View Company Industry Hub

Kernel

Kernel Team

View Company Industry Hub

Synchron

Synchron Team

View Company Industry Hub

Clear Labs

Clear Labs Team

View Company Industry Hub

BioAge Labs

BioAge Labs Team

View Company Industry Hub

Karius

Karius Team

View Company Industry Hub

CAMP4 Therapeutics

CAMP4 Therapeutics Team

View Company Industry Hub

Discover Now

Newsroom and topic pages connected to ROME Therapeutics.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Founder profile→United States startup directory→Startups in United States→Biotech hub→Biotech startup list→Series B startup list→Series B newsroom→Biotech startups in United States→Founder directory→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About ROME Therapeutics

Common questions people ask about this profile.

What is ROME Therapeutics?

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Who founded ROME Therapeutics?

ROME Therapeutics is associated with ROME Therapeutics Team on 100Xfounder.

Where is ROME Therapeutics located?

ROME Therapeutics is listed in Boston, Massachusetts, USA.

What stage is ROME Therapeutics in?

ROME Therapeutics is currently mapped to Series B. Funding context: Andreessen Horowitz, $50M Series B in 2021, $70M valuation

What is the latest funding round of ROME Therapeutics?

ROME Therapeutics's latest tracked round is Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation. Total tracked rounds: 1.

Is ROME Therapeutics hiring now?

ROME Therapeutics hiring status: Open Roles.

What technologies does ROME Therapeutics use?

ROME Therapeutics is associated with AWS, React, Python, and PostgreSQL.

Is ROME Therapeutics verified on 100Xfounder?

Yes. ROME Therapeutics is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with ROME Therapeutics founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.